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Abstract
 
Microarrays are revolutionizing genetics by making it possible to genotype hundreds of thousands of DNA markers and to assess
the expression (RNA transcripts) of all of the genes in the genome. Microarrays are slides the size of a postage stamp that
contain millions of DNA sequences to which single-stranded DNA or RNA can hybridize. This miniaturization requires little
DNA or RNA and makes the method fast and inexpensive; multiple assays of each target make the method highly accurate.
DNA microarrays with hundreds of thousands of DNA markers have made it possible to conduct systematic scans of the entire
genome to identify genetic associations with complex disorders or dimensions likely to be inﬂuenced by many genes of small
effect size. RNA microarrays can provide snapshots of gene expression across all of the genes in the genome at any time in any
tissue, which has far-reaching applications such as structural and functional ‘genetic neuroimaging’ and providing a biological
basis for understanding environmental inﬂuence.
 
Introduction
 
The goal of behavioural genomics is to understand the
developmental pathways between genes and behaviour,
not just for a single gene and a single behaviour, but for
the system that includes all genes (the genome) and all
behaviours (the behavioural phenome) (Plomin, DeFries,
Craig & McGufﬁn, 2003). The ﬁrst step in these path-
ways between the genome and the phenome is the tran-
scriptome – DNA throughout the genome that is
expressed (transcribed from DNA to RNA). Every cell
with a nucleus has the same genome but only a minority
of the genes are expressed in quantities large enough to
have an effect. Development can be viewed as the process
by which the genome becomes differently expressed in
different cells. Gene expression is a highly complex and
tightly regulated process that governs development and
also allows a cell to respond to the environment inside
and outside the cell. Not just an ‘on/off’ switch for each
gene, gene expression is a ‘volume control’ that increases
or decreases the level of expression as needed.
Although it might seem like science ﬁction, it is now
possible to study the entire genome (DNA) and the tran-
scriptome (RNA), thanks to DNA microarrays that can
assess sequence variation in all the genes in the genome
and RNA microarrays that can assess expression levels
of all the RNA transcripts in the genome. Microarrays
detect DNA and RNA in the traditional way by taking
advantage of the double-stranded nature of DNA and
the binding (hybridization) of short single-stranded bits
of DNA and RNA to their complements. The difference
is that microarrays can do this for all the genes in the
genome on a slide the size of a postage stamp. This mini-
aturization makes it is possible to assess the entire genome
or the entire transcriptome quickly in a cost-effective
manner using very little DNA or RNA. Arrays are also
very accurate because miniaturization makes it possible
to assess each target many times. Details about how
microarrays work are available elsewhere (http://www.ncbi.
nlm.nih.gov/About/primer/microarrays.html;  http://www.
bio.davidson.edu/courses/genomics/chip/chip.html).
 
DNA
 
Working with DNA is much easier than RNA because
DNA does not change across time or tissue. That is, DNA
can be obtained just once at any time during develop-
ment because the DNA sequence does not change dur-
ing development or in response to the environment. In
addition, DNA can be extracted from any cells that have
a nucleus; most frequently used are white blood cells
(red blood cells do not have nuclei) and cells from the
inside of the cheek. DNA microarrays are currently
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available commercially that genotype 500,000 DNA markers
(called single-nucleotide polymorphisms, SNPs) distributed
throughout the genome (Affymetrix, 2004).
SNP microarrays have made it possible to conduct
genome-wide association scans for complex traits and
common disorders whose genetic inﬂuence is likely to be
due to many genes of small effect, called quantitative trait
loci (QTLs) (Hirschhorn & Daly, 2005). Such genome-wide
association scans also raise new analytic problems
(Carlson, Eberle, Kruglyak & Nickerson, 2004; Freimer
& Sabatti, 2005; Thomas, Haile & Duggan, 2005; Wang,
Barratt, Clayton & Todd, 2005). Even though each
microarray is expensive and can be used only once, many
DNA microarray studies are under way genotyping
thousands of subjects in order to achieve the power needed
to detect QTLs of small effect size. It is also possible to
reduce the cost of DNA microarray studies dramatically
by pooling DNA from many individuals in a group (such
as cases or controls) and genotyping the pooled DNA
on a single DNA microarray (Butcher, Meaburn, Liu,
Hill, Al-Chalabi, Plomin, Schalkwyk & Craig, 2004;
Meaburn, Butcher, Liu, Fernandes, Hansen, Al-Chalabi,
Plomin, Craig & Schalkwyk, 2005; Meaburn, Butcher,
Schalkwyk & Plomin, 2006). This method, which we call
SNP Microarrays and Pooling (SNP-MaP), averages allele
frequency estimates biologically for each group rather
than obtaining allele frequencies for each individual in a
group and then averaging them statistically across the
group. We have applied the SNP-MaP approach to iden-
tify four SNPs associated with general cognitive ability
(Butcher, Meaburn, Knight, Sham, Schalkwyk, Craig &
Plomin, 2005).
Finding genes is expensive and difﬁcult but using genes
in research once the genes are identiﬁed is inexpensive
and easy. We predict that disorder-speciﬁc DNA micro-
arrays will be widely used in all the life sciences to geno-
type not just a few candidate genes but rather hundreds
of SNPs associated with each disorder. With microarrays
it would not matter if there were thousands of SNPs. For
example, many SNPs in each gene might be needed to
capture the genetic variation of the gene, and different
sets of SNPs are likely to be associated with different
developmental stages, with different aspects of the disorder,
with different sexes, etc.
The unique strength of DNA associations is that these
correlations are causal: DNA sequence variations do not
change in response to behaviour or the environment. For
this reason, DNA microarrays that contain as many SNPs
as needed to account for the heritable variation in dis-
orders can offer an early warning system to predict prob-
lems before they emerge in development, leading to hope
for behavioural and environmental interventions that
can prevent the disorders.
 
RNA
 
In contrast to DNA itself, the transcription of DNA to
RNA is very labile and speciﬁc to tissues and to cells
within tissues because gene expression is responsive to
the cellular and extra-cellular environment. Because RNA
degrades quickly, gene expression can be indexed by the
number of RNA transcripts in a particular tissue. RNA
microarrays make it possible to take snapshots of pro-
ﬁles of gene expression throughout the genome for different
groups (most notably, cases versus controls), at different
times (for example, during development or before and
after interventions) and in different tissues (for example,
in different brain regions). There are scores of studies
that have investigated mean differences in gene expres-
sion proﬁles between groups including cases versus con-
trols for psychiatric disorders (Konradi, 2005), as well as
many reports of changes in gene expression proﬁling, for
example, in response to drugs (Yuferov, Nielsen, Butel-
man & Kreek, 2005). Although a review in 2004 of 5000
early gene expression studies found little evidence for
reliability or validity (Miklos & Maleszka, 2004), dramatic
improvements have been made during the past three
years in relation to gene expression arrays and their analysis
(e.g. Allison, Cui, Page & Sabripour, 2006; Cobb 
 
et al.
 
, 2005).
Another problem, the difﬁculty of making sense of the
huge amount of data generated by RNA arrays, has also
been ameliorated by the availability of databases and
programmes that can be used to organize regulated
genes according to their function and cellular location
(Allison 
 
et al.
 
, 2006; Konradi, 2005).
Gene expression proﬁling of the brain is like structural
genetic neuroimaging in that it can create an atlas of
localized patterns of gene expression throughout the
brain. Because genetic neuroimaging requires brain tissue,
its use in the human species is limited to post-mortem
brains and tissue samples removed during surgery such
as tumours (Yamasaki, Koyanagi, Fujii, Itoh, Barrero,
Tamura, Yamaguchi-Kabata, Tanino, Takeda, Fukuchi,
Miyazaki, Nomura, Sugano, Imanishi & Gojobori, 2005),
which raise questions about lack of control concerning
gene expression at the time of death (Konradi, 2005).
For this reason, structural genetic neuroimaging research
has primarily been investigated in fruit ﬂies and mice
rather than the human species.
Structural brain maps of gene expression are funda-
mental because genes can only function if they are
expressed. The next goal is functional genetic neuroimaging
– studying changes in gene expression in the brain across
time, for example, during development or following
interventions such as drugs or cognitive tasks. Such
research on brain function needs to use animal models.
For example, research on mice is under way that aims to 
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create an atlas of proﬁles of gene expression throughout
the brain during learning and memory tasks in the
Genes to Cognition research consortium (Grant, 2003;
http://www.genes2cognition.org).
Because of the practical and scientiﬁc limitations of
using post-mortem brain tissue, RNA microarrays will
be much more widely applicable to human research if
easily available tissue such as blood can be used for gene
expression proﬁling. Although the blood–brain barrier
makes it unlikely that gene expression in the brain will
be reﬂected by gene expression in the blood, many dis-
orders directly involve blood such as infections (Feezor
 
et al.
 
, 2004) and many other disorders that involve the
brain also involve blood (e.g. hormonal concomitants of
anxiety). Moreover, some links between gene expression
proﬁles in blood and brain are possible (Gladkevich,
Kauffman & Korf, 2004; Nicholson, Unger, Mangalathu,
Ojaniemi & Vernon, 2004; Pahl, 2005). Although gene
expression proﬁling in the blood cannot be used to local-
ize patterns of gene expression in the brain, blood could
be used to address some important questions, most
notably, gene expression proﬁle differences as a function
of development or interventions.
It should be emphasized that gene expression is a phe-
notype that changes in response to the environment. For
this reason, RNA microarrays could lead to a paradigm
shift in studying environmental inﬂuences on complex
behavioural disorders by focusing on proﬁles of gene
expression, the most fundamental mechanism of
environmental inﬂuence. This approach could provide
a biological foundation upon which to build an under-
standing of more complex levels of environmental ana-
lysis typically studied in behavioural research. It could
also have far-reaching impact on translational research
by providing biomarkers for differential diagnosis and
providing a biological basis for monitoring environmental
interventions such as drugs and other therapies. At the
most general level, a functional focus on the transcrip-
tome in terms of its effect on complex disorders will
lead to research that integrates the disorder-relevant
transcriptome with the genome, proteome, and eventually
the brain.
 
Non-coding RNA
 
DNA and RNA microarrays are greatly accelerating
the already fast pace of discovery in molecular genetics.
As mentioned earlier, DNA arrays have made possible
genome-wide association scans for QTLs, and RNA
arrays have facilitated genome-wide expression proﬁling.
Moreover, DNA arrays and RNA arrays are likely to open
up completely novel areas for research (Hoheisel, 2006).
One example is that research using DNA and RNA
microarrays is broadening our search for functional
sequences, which is the focus of this concluding section.
The genes coding for proteins comprise only about 2%
of the 3 billion nucleotide bases of the human genome.
Microarray research has shown that much more of the
genome is transcribed into RNA but 
 
not
 
 translated into
amino acid sequences, called non-coding RNA (Mattick,
2004). Moreover, non-coding RNA is increasingly being
shown to be functional, suggesting the need for a much
broader view of the word ‘gene’ (Mattick, 2004). Evidence
for the functionality of non-coding RNA comes from
microarray research showing that about half of all tran-
scription factor binding sites are in non-coding DNA
regions, which indicates that non-coding RNA is regulated
(Bertone, Stolc, Royce, Rozowsky, Urban, Zhu, Rinn,
Tongprasit, Samanta, Weissman, Gerstein & Snyder, 2004;
Cawley, Bekiranov, Ng, Kapranov, Sekinger, Kampa,
Piccolboni, Sementchenko, Cheng, Williams, Wheeler,
Wong, Drenkow, Yamanaka, Patel, Brubaker, Tammana,
Helt, Struhl & Gingeras, 2004). Non-coding RNA is
now known to regulate gene expression by a growing list
of mechanisms such as RNA interference, gene silencing,
and DNA demethylation (Costa, 2005).
This broader view of functional sequences is especially
important because polymorphisms in such DNA tran-
scribed into functional non-coding RNA are likely to
create subtle genetic variation in the highly pleiotropic
and polygenic systems that develop into complex traits
and common disorders. In contrast, most rare and severe
single-gene disorders are caused by mutations in coding
DNA (OMIM Online Mendelian Inheritance in Man;
OMIM, 2004). However, identifying functional sequences
in non-coding DNA is a more difﬁcult problem, and it
is also possible that sequences responsible for the regu-
lation of gene expression may evolve more rapidly than
structural genes (Pang, Frith & Mattick, 2006). We pre-
dict that polymorphisms in non-coding DNA will prove
to be an important source of QTLs responsible for the
heritability of complex human traits.
For these reasons, we predict that non-coding DNA
and its RNA will emerge as a major player in research
on the genome and transcriptome and their links with
the phenome. DNA microarrays are currently available
commercially that can genotype hundreds of thousands
of SNPs throughout the genome, thus capturing genetic
effects mediated by non-coding as well as coding DNA.
Non-coding DNA may be the answer to the question
why initial research using DNA microarrays in genome-
wide association scans points to associations with SNPs
in non-coding DNA regions (e.g. Butcher 
 
et al.
 
, 2005).
Such associations may be examples of the functional
effects of non-coding DNA. Non-coding DNA may also 
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be the reason why linkage studies that consistently point
to a chromosomal region (such as linkage to the short
arm of chromosome 6 for reading disability) have had
difﬁculty pinpointing the gene responsible for the linkage.
The linkages might not be due to genes in the traditional
sense of coding DNA; the culprits might be non-coding
DNA. Although extant DNA microarrays include SNPs
disproportionately in or near coding DNA, they will
eventually include all polymorphisms in the genome,
whether in non-coding or coding DNA.
Extant RNA arrays only assess coding RNA. Another
step function in the pace of discovery will occur when
RNA arrays are available that assess the entire transcrip-
tome, whether coding or non-coding RNA. This major
advance will happen soon because so-called tiling micro-
arrays are now available that sample DNA from the entire
genome and can be used to identify all transcribed sequences
(Bertone, Stolc, Royce, Rozowsky, Urban, Zhu, Rinn,
Tongprasit, Samanta, Weissman, Gerstein & Snyder, 2004;
Bertone, Trifonov, Rozowsky, Schubert, Emanuelsson,
Karro, Kao, Snyder & Gerstein, 2006; Washietl, Hofacker,
Lukasser, Huttenhofer & Stadler, 2005). Such research
has been facilitated by the commercial availability of
standardized microarrays such as the Affymetrix Gene-
Chip® Tiling Array Set 1.0R which provides 35-bp probe
spacing of 45 million oligonucleotide probes which can
be used for unbiased RNA transcript mapping.
 
Conclusions
 
The impact of DNA and RNA microarrays on develop-
mental science will be enormous. Developmental science
will relate the genome and transcriptome to the behavi-
oural phenome as it develops at all levels of analysis
from proteins to the brain. For each phenotype, we can
expect to identify different but overlapping sets of hun-
dreds of relevant DNA polymorphisms and RNA tran-
scripts at different developmental stages and in response
to different experiences and different treatments. As such
trait-speciﬁc, stage-speciﬁc and state-speciﬁc DNA and
RNA microarrays become available commercially, we
predict that they will be used routinely in developmental
research including translational research that identiﬁes
new drug targets, leads to improved diagnoses including
premorbid diagnoses, to personalized treatments, and espe-
cially to prevention of common developmental disorders.
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